A Study to Evaluate the Effect of Two Fixed-Dose Leucine, Sildenafil and Metformin Combinations on Blood Pressure in Individuals With Hypertension

A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.

Also called NCT07647003

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07647003
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07647003. Randomized; quadruple masking; primary purpose treatment. Start 2026-10-15 (anticipated); primary completion 2027-05-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate the Effect of Two Fixed-Dose Leucine, Sildenafil and Metformin Combinations on Blood Pressure in Individuals With Hypertension
Acronym
NS-HTN-01
Condition
Hypertension
Intervention (Drug)
NS-0200 (low sildenafil)
Intervention (Drug)
NS-0200 (higher sildenafil)
Intervention (Other)
Placebo
Lead sponsor
NuSirt Biopharma (class: industry)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct07647003
Content hash
638b08f2c0a4ca54d014a17676b2307564344eb5669a6ae87a624cade247c263